Brief: Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
21/11/2023 13:02
Nov 21 (Reuters) - Pulse Biosciences Inc PLSE.O :
* PULSE BIOSCIENCES FILES 510(K) SUBMISSION WITH U.S. FDA
FOR ITS
CELLFX NSPFA PERCUTANEOUS ELECTRODE
Source text for Eikon: ID:nBw1cJjhPa
Further company coverage: PLSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pulse Biosciences
See all newsUS RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Pulse Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Pulse Biosciences Q2 net loss widens, cash position strengthens
Pulse Biosciences Inc expected to post a loss of 36 cents a share - Earnings Preview
Brief: Pulse Biosciences, Inc. Announces Planned Redemption Of Warrants